Is Viridian Therapeutics, Inc. (VRDN) a Buy, Sell, or Hold?
Viridian Therapeutics, Inc.
NASDAQ:VRDN
$19.06 USD
-$0.02 (-0.1%)
- Volume
- 1.57M
- Average Volume
- 2.55M
- Market Capitalization
- $1.72B
- P/E Ratio
- -5.48
- Dividend Yield
- 0.00%
- Price Target
- $38.50
- Year High
- $34.29
- Year Low
- $13.18
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $15.15
NUMBER OF INSIDERS BUYING (LAST 12 MONTHS)
22
NUMBER OF INSIDERS SELLING (LAST 12 MONTHS)
13
AMOUNT OF INSIDER SELLING (LAST 12 MONTHS)
$ 70216
VRDN Estimated and Actual Revenue by Quarter
Get MSFT Insider Trade Alerts
VRDN Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| CAIN CHRISTOPHER W. | director | 2026-07-01 | A-Award | 18.48 | 2026-07-02 |
| Ajer Jeffrey Robert | director | 2026-07-01 | A-Award | 18.48 | 2026-07-02 |
| Moses Jennifer K. | director | 2026-07-01 | A-Award | 18.48 | 2026-07-02 |
| Gheuens Sarah | director | 2026-07-01 | A-Award | 18.48 | 2026-07-02 |
| Kiselak Tomas | director | 2026-07-01 | A-Award | 18.48 | 2026-07-02 |
| Morris Arlene | director | 2026-07-01 | A-Award | 18.48 | 2026-07-02 |
| Fairmount Funds Management LLC | director, 10 percent owner: | 2026-05-11 | P-Purchase | 17 | 2026-05-13 |
| Harmon Seth | officer: Chief Financial Officer | 2026-03-03 | F-InKind | 30.19 | 2026-03-09 |
| Beetham Thomas W. | officer: Chief Operating Officer | 2026-03-03 | F-InKind | 30.19 | 2026-03-09 |
| Tousignant Jennifer | officer: Chief Legal Officer | 2026-03-03 | F-InKind | 30.19 | 2026-03-09 |
| Mahoney Stephen F. | director, officer: President and CEO | 2026-03-03 | F-InKind | 30.19 | 2026-03-09 |
| Tousignant Jennifer | officer: Chief Legal Officer | 2026-03-02 | A-Award | 30.25 | 2026-03-04 |
| Tousignant Jennifer | officer: Chief Legal Officer | 2026-03-02 | A-Award | 0 | 2026-03-04 |
| Tousignant Jennifer | officer: Chief Legal Officer | 2026-03-03 | M-Exempt | 0 | 2026-03-04 |
| Tousignant Jennifer | officer: Chief Legal Officer | 2026-03-03 | M-Exempt | 0 | 2026-03-04 |
| Tousignant Jennifer | officer: Chief Legal Officer | 2026-03-03 | F-InKind | 29.32 | 2026-03-04 |
| Harmon Seth | officer: Chief Financial Officer | 2026-03-02 | A-Award | 30.25 | 2026-03-04 |
| Harmon Seth | officer: Chief Financial Officer | 2026-03-02 | A-Award | 0 | 2026-03-04 |
| Harmon Seth | officer: Chief Financial Officer | 2026-03-03 | M-Exempt | 0 | 2026-03-04 |
| Harmon Seth | officer: Chief Financial Officer | 2026-03-03 | M-Exempt | 0 | 2026-03-04 |
| Harmon Seth | officer: Chief Financial Officer | 2026-03-03 | F-InKind | 29.32 | 2026-03-04 |
| Harmon Seth | 2025-03-03 | 0 | 2026-03-04 | ||
| Tousignant Jennifer | 2025-03-03 | 0 | 2026-03-04 | ||
| Beetham Thomas W. | officer: Chief Operating Officer | 2026-03-02 | A-Award | 30.25 | 2026-03-04 |
| Beetham Thomas W. | officer: Chief Operating Officer | 2026-03-02 | A-Award | 0 | 2026-03-04 |
| Beetham Thomas W. | officer: Chief Operating Officer | 2026-03-03 | M-Exempt | 0 | 2026-03-04 |
| Beetham Thomas W. | officer: Chief Operating Officer | 2026-03-03 | M-Exempt | 0 | 2026-03-04 |
| Beetham Thomas W. | officer: Chief Operating Officer | 2026-03-03 | F-InKind | 29.32 | 2026-03-04 |
| Mahoney Stephen F. | officer: President and CEO | 2026-03-02 | A-Award | 30.25 | 2026-03-04 |
| Mahoney Stephen F. | officer: President and CEO | 2026-03-02 | A-Award | 0 | 2026-03-04 |
| Mahoney Stephen F. | officer: President and CEO | 2026-03-03 | M-Exempt | 0 | 2026-03-04 |
| Mahoney Stephen F. | officer: President and CEO | 2026-03-03 | M-Exempt | 0 | 2026-03-04 |
| Mahoney Stephen F. | officer: President and CEO | 2026-03-03 | F-InKind | 29.32 | 2026-03-04 |
| Tripuraneni Radhika | officer: Chief Medical Officer | 2026-03-02 | A-Award | 30.25 | 2026-03-04 |
| Tripuraneni Radhika | officer: Chief Medical Officer | 2026-03-02 | A-Award | 0 | 2026-03-04 |
| Tousignant Jennifer | officer: Chief Legal Officer | 2025-12-31 | S-Sale | 31.16 | 2026-01-02 |
| Fairmount Funds Management LLC | director, 10 percent owner: | 2025-10-23 | P-Purchase | 22 | 2025-10-27 |
| CAIN CHRISTOPHER W. | director | 2025-07-01 | A-Award | 14.47 | 2025-07-02 |
| Kiselak Tomas | director | 2025-07-01 | A-Award | 14.47 | 2025-07-02 |
| Morris Arlene | director | 2025-07-01 | A-Award | 14.47 | 2025-07-02 |
| Ajer Jeffrey Robert | director | 2025-07-01 | A-Award | 14.47 | 2025-07-02 |
| Gheuens Sarah | director | 2025-07-01 | A-Award | 14.47 | 2025-07-02 |
| Moses Jennifer K. | director | 2025-07-01 | A-Award | 14.47 | 2025-07-02 |
| Fairmount Funds Management LLC | director, 10 percent owner: | 2025-06-10 | M-Exempt | 12.31 | 2025-06-11 |
| Fairmount Funds Management LLC | director, 10 percent owner: | 2025-06-09 | M-Exempt | 7.8 | 2025-06-11 |
| Fairmount Funds Management LLC | director, 10 percent owner: | 2025-06-10 | M-Exempt | 12.31 | 2025-06-11 |
| Fairmount Funds Management LLC | director, 10 percent owner: | 2025-06-09 | M-Exempt | 7.8 | 2025-06-11 |
| Ajer Jeffrey Robert | director | 2025-04-07 | A-Award | 11.78 | 2025-04-09 |
| Ajer Jeffrey Robert | 2025-04-07 | 0 | 2025-04-09 | ||
| Tripuraneni Radhika | officer: Chief Medical Officer | 2025-03-10 | A-Award | 15.58 | 2025-03-12 |
| Tripuraneni Radhika | officer: Chief Medical Officer | 2025-03-10 | 13.21 | 2025-03-12 | |
| CAIN CHRISTOPHER W. | director | 2025-03-10 | A-Award | 15.58 | 2025-03-12 |
| CAIN CHRISTOPHER W. | 2025-03-10 | 0 | 2025-03-12 | ||
| Tousignant Jennifer | officer: Chief Legal Officer | 2025-03-03 | A-Award | 14.41 | 2025-03-04 |
| Tousignant Jennifer | officer: Chief Legal Officer | 2025-03-03 | A-Award | 0 | 2025-03-04 |
| Mahoney Stephen F. | director, officer: President and CEO | 2025-03-03 | A-Award | 14.41 | 2025-03-04 |
| Mahoney Stephen F. | director, officer: President and CEO | 2025-03-03 | A-Award | 0 | 2025-03-04 |
| Beetham Thomas W. | officer: Chief Operating Officer | 2025-03-03 | A-Award | 14.41 | 2025-03-04 |
| Beetham Thomas W. | officer: Chief Operating Officer | 2025-03-03 | A-Award | 0 | 2025-03-04 |
| Harmon Seth | officer: Chief Financial Officer | 2025-03-03 | A-Award | 14.41 | 2025-03-04 |
| Harmon Seth | officer: Chief Financial Officer | 2025-03-03 | A-Award | 0 | 2025-03-04 |
| Beetham Thomas W. | officer: Chief Operating Officer | 2024-09-27 | P-Purchase | 23.41 | 2024-09-30 |
| Mahoney Stephen F. | director, officer: President and CEO | 2024-09-27 | P-Purchase | 23.33 | 2024-09-30 |
| Fairmount Funds Management LLC | director, 10 percent owner: | 2024-09-13 | P-Purchase | 18.75 | 2024-09-17 |
| Gheuens Sarah | director | 2024-06-26 | A-Award | 12.31 | 2024-06-28 |
| Morris Arlene | director | 2024-06-26 | A-Award | 12.31 | 2024-06-28 |
| Moses Jennifer K. | director | 2024-06-26 | A-Award | 12.31 | 2024-06-28 |
| Harwin Peter Evan | director | 2024-06-26 | A-Award | 12.31 | 2024-06-28 |
| Kiselak Tomas | director | 2024-06-26 | A-Award | 12.31 | 2024-06-28 |
| Fairmount Funds Management LLC | director, 10 percent owner: | 2024-03-28 | J-Other | 0 | 2024-04-01 |
| Fairmount Funds Management LLC | director, 10 percent owner: | 2024-03-28 | J-Other | 0 | 2024-04-01 |
| Fairmount Funds Management LLC | director, 10 percent owner: | 2024-03-28 | J-Other | 0 | 2024-04-01 |
| Fairmount Funds Management LLC | director, 10 percent owner: | 2024-03-28 | J-Other | 0 | 2024-04-01 |
| Tousignant Jennifer | 2024-02-12 | 0 | 2024-02-14 | ||
| Tousignant Jennifer | officer: Chief Legal Officer | 2024-02-12 | A-Award | 19.68 | 2024-02-14 |
| Ciulla Thomas | officer: Chief Medical Officer | 2024-02-05 | A-Award | 18.7 | 2024-02-07 |
| Fairmount Funds Management LLC | director, 10 percent owner, other: See Remarks | 2024-01-22 | P-Purchase | 21 | 2024-01-24 |
| Ciulla Thomas | officer: Chief Medical Officer | 2024-01-03 | 0 | 2024-01-12 | |
| Ciulla Thomas | officer: Chief Medical Officer | 2024-01-03 | 13.76 | 2024-01-12 | |
| Ciulla Thomas | officer: Chief Medical Officer | 2024-01-03 | 33.06 | 2024-01-12 | |
| Ciulla Thomas | officer: Chief Medical Officer | 2024-01-03 | 28.22 | 2024-01-12 | |
| Harmon Seth | officer: See Remarks | 2023-11-10 | A-Award | 13.76 | 2023-11-13 |
| Fairmount Funds Management LLC | director, 10 percent owner: | 2023-10-30 | A-Award | 0 | 2023-11-01 |
| Beetham Thomas W. | 2023-10-30 | 0 | 2023-11-01 | ||
| Beetham Thomas W. | officer: Chief Operating Officer | 2023-10-30 | A-Award | 13.02 | 2023-11-01 |
| Mahoney Stephen F. | director, officer: President and CEO | 2023-10-30 | A-Award | 13.02 | 2023-11-01 |
| Mahoney Stephen F. | 2023-10-30 | 0 | 2023-11-01 | ||
| Gheuens Sarah | director | 2023-09-21 | A-Award | 15.74 | 2023-09-25 |
| Gheuens Sarah | 2023-09-21 | 0 | 2023-09-25 | ||
| Harmon Seth | officer: See Remarks | 2023-09-12 | 24.5 | 2023-09-19 | |
| Meisner Lara | officer: Chief Legal Officer | 2023-06-15 | M-Exempt | 23.03 | 2023-06-20 |
| Meisner Lara | officer: Chief Legal Officer | 2023-06-16 | M-Exempt | 23.03 | 2023-06-20 |
| Meisner Lara | officer: Chief Legal Officer | 2023-06-15 | M-Exempt | 23.03 | 2023-06-20 |
| Meisner Lara | officer: Chief Legal Officer | 2023-06-16 | M-Exempt | 23.03 | 2023-06-20 |
| Meisner Lara | officer: Chief Legal Officer | 2023-06-16 | S-Sale | 28.35 | 2023-06-20 |
| Meisner Lara | officer: Chief Legal Officer | 2023-06-15 | S-Sale | 28.02 | 2023-06-20 |
| Harwin Peter Evan | director | 2023-06-14 | A-Award | 27.67 | 2023-06-16 |
| Moses Jennifer K. | director | 2023-06-14 | A-Award | 27.67 | 2023-06-16 |
| Kiselak Tomas | director | 2023-06-14 | A-Award | 27.67 | 2023-06-16 |
| Morris Arlene | director | 2023-06-14 | A-Award | 27.67 | 2023-06-16 |